pubmed-article:2570803 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C0021289 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C1167395 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C0004561 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C0039082 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C0443146 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C1332714 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C1704410 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C1515877 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
pubmed-article:2570803 | lifeskim:mentions | umls-concept:C0002131 | lld:lifeskim |
pubmed-article:2570803 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:2570803 | pubmed:dateCreated | 1989-10-20 | lld:pubmed |
pubmed-article:2570803 | pubmed:abstractText | The induction of transplantation tolerance to H-2b alloantigens in BALB/c (H-2d) mice by neonatal injection of (C57BL/6 x BALB/c)F1 spleen cells, produces an autoimmune lupus-like syndrome due to an activation of persisting F1 donor B cells. This syndrome is characterized by hypergammaglobulinaemia, high levels of anti-DNA antibodies, as well as by circulating immune complexes and glomerular deposits of Ig. The role of host T cells in this model was investigated by using athymic BALB/c nu/nu mice as recipients of normal (C57BL/6 x BALB.Igb)F1 spleen cells. In these "tolerized" BALB/c nu/nu mice, there was a persistence of F1 donor B cells but none of the autoimmune features were expressed, conversely to tolerized BALB/c nu/+ littermates. The injection of CD4+CD8- T lymphocytes from adult normal BALB/c mice in 3-wk-old tolerized BALB/c nu/nu mice triggered the appearance of all the autoimmune findings observed in euthymic tolerant mice. The autoantibodies were produced by persisting F1 donor B cells as shown by allotype analysis. More strikingly, a similar triggering of the autoimmune syndrome, including high titers of anti-DNA IgG antibodies and circulating immune complexes, was observed after injection of CD4+CD8- T cells from 2-wk-old tolerant BALB/c mice into "tolerized" BALB/c nu/nu mice. The anti-ssDNA antibodies were shown to bear only the Ighb allotype, indicating their exclusive origin from F1 donor B cells. These results imply that CD4+ T cells from the tolerant mice are necessary for the activation of autoreactive F1 B cells and for the development of the autoimmune syndrome occurring in this model. They also suggest that, although there is a marked depletion of H-2b-specific alloreactive CTL precursors in those neonatally tolerized mice, this state of tolerance can be associated with the persistence of H-2b-specific alloreactive CD4+ cells. | lld:pubmed |
pubmed-article:2570803 | pubmed:language | eng | lld:pubmed |
pubmed-article:2570803 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2570803 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:2570803 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2570803 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2570803 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2570803 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2570803 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2570803 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2570803 | pubmed:month | Oct | lld:pubmed |
pubmed-article:2570803 | pubmed:issn | 0022-1767 | lld:pubmed |
pubmed-article:2570803 | pubmed:author | pubmed-author:LambertP HPH | lld:pubmed |
pubmed-article:2570803 | pubmed:author | pubmed-author:IzuiSS | lld:pubmed |
pubmed-article:2570803 | pubmed:author | pubmed-author:MerinoJJ | lld:pubmed |
pubmed-article:2570803 | pubmed:author | pubmed-author:DuchosalM AMA | lld:pubmed |
pubmed-article:2570803 | pubmed:author | pubmed-author:SchurmansSS | lld:pubmed |
pubmed-article:2570803 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2570803 | pubmed:day | 1 | lld:pubmed |
pubmed-article:2570803 | pubmed:volume | 143 | lld:pubmed |
pubmed-article:2570803 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2570803 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2570803 | pubmed:pagination | 2202-8 | lld:pubmed |
pubmed-article:2570803 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:meshHeading | pubmed-meshheading:2570803-... | lld:pubmed |
pubmed-article:2570803 | pubmed:year | 1989 | lld:pubmed |
pubmed-article:2570803 | pubmed:articleTitle | Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells. | lld:pubmed |
pubmed-article:2570803 | pubmed:affiliation | WHO Immunology Research and Training Centre, Department of Pathology, Geneva, Switzerland. | lld:pubmed |
pubmed-article:2570803 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2570803 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2570803 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2570803 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2570803 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2570803 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2570803 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2570803 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2570803 | lld:pubmed |